Paving the Way for Biomedical Innovation

The Frederick National Laboratory is meeting the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

HIV/AIDS Research

Study establishes measurement for factor affecting immune response to HIV

HIV ravages the immune system in people who acquire it, but not everyone is affected equally. In some of these individuals...
Drug Development

Biopharmaceutical Development Program embarks on new work for targeted cancer therapy

The Biopharmaceutical Development Program (BDP) has entered a new area of investigational cancer treatment development: an...

‘What a scientist looks like’: Women in science describe adversity and success 

There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four panelists...

Specific retinoid shrinks immune checkpoint-resistant lung cancers in mice

Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a standard...
HIV/AIDS Research

New drug to treat HIV might also be used to block infection altogether

Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for a new...
Biomedical Imaging

Morehouse School of Medicine biospecimens to boost diversity of cancer samples for proteogenomic analysis

A national effort to understand the molecular basis of numerous cancers by analyzing proteins and genes will benefit from...
Cancer Research

AI enhances method for rapid diagnosis, potentially better treatment of endometrial cancer

Artificial intelligence has helped researchers uncover potential avenues for better treatment of endometrial cancer, the most...
What is this?

Representative picture of colon of infected RM- that was infused with engineered CD8+ T cells to reduce the viral load. The Tissue Analysis and Retroviral Protein Core provides state-of-the-art tissue analysis capabilities.

Information
Initiative

Scientific Standards Hub

Our scientists establish standards and reference reagents for diverse scientific  disciplines and  encourage the adoption of benchmarks  among researchers. 
8
disciplines with tools to help bridge gaps in scientific reproducibility.
Initiative

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.
220,000
People per year in the U.S. are diagnosed with cancers caused by KRAS mutations.
What is this? Surface representation of the structure of an oncogenic mutant of KRAS in complex with RAS-binding domains of RAF1 Kinase. The GMPPNP bound to oncogenic KRAS mutant is shown in ball-and-stick representation.
Information

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.